Trends in Neurosciences: MicroPET imaging and transgenic models: a blueprint for Alzheimer's disease clinical research

Trends in Neurosciences Trends in Neurosciences RSS feed. For more information, go to http://www.cell.com/trends/neurosciences

MicroPET imaging and transgenic models: a blueprint for Alzheimer's disease clinical research Aug 20th 2014, 00:00, by Eduardo R. Zimmer, Maxime J. Parent, A. Claudio Cuello, Serge Gauthier, Pedro Rosa-Neto AD is currently conceptualized as a progressive pathophysiological process, initially characterized by amyloidosis (extracellular Aβ accumulation; see Glossary), followed by a cascade of neurodegenerative events, including the formation of neurofibrillary tangles (NFTs, intracellular tau protein aggregates), neuroinflammation, and neurotransmission abnormalities, ultimately leading to cognitive decline and dementia [1–3]. In the past decade, developments in radiopharmaceutical research have allowed the synthesis of highly specific PET imaging agents, which have allowed the in vivo quantification of amyloid deposition in AD patients [4].

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions